Do you need to find out in what countries a certain drug is approved and reimbursed? Do you need to routinely follow what is happening regarding the market access landscape for small molecule and biologic drugs in your therapeutic area? And are you spending too much time searching for trustworthy information needed to inform your pricing and reimbursement strategy for payers?

Certara’s Market Access Radar (MAR) database and online repository was designed to be your go-to resource providing you in minutes with the most critical information relevant to market access. Expert-curated, then hosted in MAR, our consultants gather the latest reimbursement recommendations, information on financing from public funds announced by Ministries of Health (MOH) and Health Technology Assessment (HTA) agencies, and changes in legal provisions regulating the financing of health technologies from public funds and much more.

Join the Certara Evidence & Access team for a presentation on how MAR is being used to help our clients succeed with their commercialization strategy. We’ll also provide a product demonstration of its core features followed by a Q&A session